MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT07028853 | RECRUITING | PHASE3
1000 participants

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-09-28
Completion:
2028-09-12
Conditions
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Hormone Sensitive Prostate Cancer
  • Prostate Cancer
  • Cancer of the Prostate
Interventions
  • DRUG
No Results Yet
NCT07023289 | RECRUITING | PHASE2
140 participants

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-09-02
Completion:
2029-11-30
Conditions
  • Colorectal Cancer
Interventions
  • DRUG
No Results Yet
NCT07005102 | RECRUITING | PHASE2/PHASE3
854 participants

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-08-03
Completion:
2031-12-31
Conditions
  • Non-Squamous Non-Small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT06998940 | RECRUITING | PHASE3
94 participants

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2026-05-13
Completion:
2029-12-31
Conditions
  • Locally Advanced Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Adenocarcinoma
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06993233 | RECRUITING | PHASE2
96 participants

A Study With CIT-013 in HS Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-10-31
Completion:
2027-04-30
Conditions
  • Hidradenitis Suppurativa (HS)
Interventions
  • DRUG
No Results Yet
NCT06992544 | ACTIVE_NOT_RECRUITING | NA
97 participants

Trial of Pistachio Consumption in Older Adults

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-05-28
Completion:
2026-07-31
Conditions
  • Cognition
  • Cardiometabolic Risk Factors
  • Life Satisfaction
Interventions
  • OTHER
No Results Yet
NCT06991114 | RECRUITING | PHASE2
90 participants

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-07-09
Completion:
2028-01-31
Conditions
  • Refractory Rheumatoid Arthritis (RA)
  • Idiopathic Inflammatory Myopathies (IIMs)
  • Systemic Sclerosis (SSc)
  • Rheumatoid Arthritis (RA
  • IIM
  • Myositis
  • Scleroderma
  • Sjogren Syndrome
  • Sjogrens Disease
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page